Back
First Trust Nasdaq BuyWrite Income ETF Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Buy
69
FTQI
First Trust Nasdaq BuyWrite Income ETF
Last Price:
$20.98
Seasonality Move:
-0.13%
Sell
41
MNPR
Monopar Therapeutics, Inc.
Last Price:
$70.68
Seasonality Move:
25.93%
Buy
69
First Trust Nasdaq BuyWrite Income ETF (FTQI)
is a Buy
Is First Trust Nasdaq BuyWrite Income ETF a Buy, Sell or Hold?
-
The current First Trust Nasdaq BuyWrite Income ETF [FTQI] share price is $20.90. The Score for FTQI is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
FTQI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $70.50. The Score for MNPR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FTQI Stock Price Chart
What is First Trust Nasdaq BuyWrite Income ETF's stock price today?
-
The First Trust Nasdaq BuyWrite Income ETF share price today is $20.90Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FTQI is experiencing slight buying pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $70.50Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.
FTQI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 54.37 | Buy |
| Chaikin Money Flow: | 28690 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.47 - 20.95) | Buy |
| Bollinger Bands (100): | (20.23 - 20.91) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.48 | Sell |
| Relative Strength Index (14 RSI): | 40.78 | Sell |
| Chaikin Money Flow: | -194871 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (71.3 - 85.58) | Sell |
| Bollinger Bands (100): | (46.5 - 89.48) | Buy |
FTQI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.73 | Buy |
| 20-day SMA: | 20.79 | Buy |
| 50-day SMA: | 20.79 | Buy |
| 200-day SMA: | 19.81 | Buy |
| 8-day EMA: | 20.76 | Buy |
| 20-day EMA: | 20.77 | Buy |
| 50-day EMA: | 20.72 | Buy |
| 200-day EMA: | 20.29 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 70.62 | Sell |
| 20-day SMA: | 76.51 | Sell |
| 50-day SMA: | 80.5 | Sell |
| 200-day SMA: | 52.75 | Buy |
| 8-day EMA: | 71.14 | Sell |
| 20-day EMA: | 74.96 | Sell |
| 50-day EMA: | 76.33 | Sell |
| 200-day EMA: | 56.96 | Buy |
First Trust Nasdaq BuyWrite Income ETF Earnings Growth & FTQI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
First Trust Nasdaq BuyWrite Income ETF Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||